Form 4 for DGX Quest Diagnostics
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001022079-23-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,442 | 40.9K | +6% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $147.86 | -811 | 38.4K | -2% | -$119.9K |
| D | 2023-02-27 | 2023-02-24 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $141.42 | -1,415 | 39.4K | -3% | -$200.1K |
| D | 2023-02-27 | 2023-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +9,653 | 9,653 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | A | A | 2,442 | $0.00 | 40,855 | D | — | — | (F2) Represents an award of restricted share units. |
| 2 | Common | Common Stock | 2023-02-23 | F | D | 811 | $147.86 | 38,413 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |
| 3 | Common | Common Stock | 2023-02-24 | S | D | 1,415 | $141.42 | 39,440 | D | — | — | |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2023-02-23 | A | A | 9,653 | $0.00 | 9,653 | D | $143.33 · — to 2033-02-23 | 9,653 Common Stock | (F5) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |